Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Ellen 't Hoen
51 POSTS
0 COMMENTS
http://medicineslawandpolicy.org
Wrapping up 2021 – some noteworthy medicines law and policy events
Ellen 't Hoen
-
December 24, 2021
Imagine if health and trade ministers would meet in one room this week
Ellen 't Hoen
-
November 30, 2021
The EU proposed Covid waivers of certain TRIPS rules are mostly meaningless
Medicines Law & Policy
-
October 14, 2021
Vaccine knowledge needs to be a global public good: Remarks to the World Trade...
Ellen 't Hoen
-
July 22, 2021
Covid shows the world it needs new rules to deal with pandemics
Ellen 't Hoen
-
May 21, 2021
Dutch Health Care Institute Says No to Medicines Pirate
Ellen 't Hoen
-
March 29, 2021
The elephant in the room at the WHO Executive Board
Ellen 't Hoen
-
January 22, 2021
Some Surprises in the European Commission’s New Intellectual Property Strategy
Ellen 't Hoen
-
December 2, 2020
Dutch Court Orders AstraZeneca to Pay Damages in Patent Evergreening Case
Ellen 't Hoen
-
October 14, 2020
WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis
Ellen 't Hoen
-
October 14, 2020
1
2
3
...
6
Page 1 of 6
This work is licensed under Creative Commons.